Status:
COMPLETED
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
Lead Sponsor:
National Jewish Health
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Asthma
Eligibility:
All Genders
Up to 18 years
Brief Summary
The study compares the biochemical markers in bronchoalveolar lavage samples from asthmatic children to those markers found in non-asthmatic children with other respiratory diseases. The investigators...
Eligibility Criteria
Inclusion
- 18 years of age or younger
- Scheduled for bronchoscopy at National Jewish Health for persistent asthma, persistent, poorly controlled wheezing, chronic cough, GERD, atelectasis, bronchopulmonary dysplasia, infection.
- Consent and assent from parent and patient \[if appropriate\].
Exclusion
- Unwillingness to consent/assent to retrieval of BAL fluid for research analysis.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2018
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00838552
Start Date
October 1 2007
End Date
June 21 2018
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206